Non-invasive market RSP Systems focuses on non-invasive glucose sensing, presenting a unique growth opportunity in digital health and remote monitoring markets. This aligns with buyers seeking painless, continuous glucose data and could open opportunities with healthcare providers and insurers looking to reduce invasive testing costs and improve patient compliance.

EU funding leverage With significant backing from Horizon 2020 and a total funding pool around 44 million, there is a demonstrated validation and potential co-investment interest. This can be used to engage partners and customers by highlighting strong R&D credibility and potential for collaborative pilots and joint grants.

Strategic partnerships Past and potential collaborations with global players like Trumpf and Brenmiller Energy indicate a channel strategy that can be leveraged to access industrial, healthcare, and energy sectors. Targeting co-development deals or distribution partnerships could accelerate market entry and broaden revenue streams.

Early-stage revenue focus Current revenue is under one million, signaling a startup phase with high growth potential. This is a chance to propose phased pilots, proofs of concept, and flexible commercial terms to win early adopters in hospitals, clinics, and chronic care management programs.

Technology stack fit Utilizing cloud, web, and analytics tools (Azure, WordPress, Webflow, Ruby) suggests capability for scalable remote monitoring platforms and customer-facing dashboards. This can be marketed to healthcare IT teams as a ready-to-integrate solution with strong data handling, security, and user experience advantages.